Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Bio-Matrix Scientific provides update on dCellVax for breast cancer

Sep. 27, 2013

Merck KGaA to renew testing of lung cancer vaccine

Sep. 27, 2013

Trastuzumab emtansine receives committee recommendation in E.U.

Sep. 23, 2013

OncoMed Pharmaceuticals begins phase Ib/II trial of demcizumab in ovarian cancer

Sep. 23, 2013

Chugai gains Japanese approval for HER2-targeted antibody-drug conjugate

Sep. 20, 2013

Prima BioMed reports topline data from phase II CVac trial

Sep. 20, 2013

Agenus reports follow-on phase II data for brain cancer vaccine

Sep. 19, 2013

Provenge obtains European approval

Sep. 18, 2013

Cancer vaccine KRM-20 evaluated in phase I prostate cancer trial

Sep. 18, 2013

arGEN-X files CTA for first-in-man ARGX-111 cancer study

Sep. 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...